Debt-to-equity of Lomond Therapeutics Holdings, Inc. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Lomond Therapeutics Holdings, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Lomond Therapeutics Holdings, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 34%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Lomond Therapeutics Holdings, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 34% +38% 30 Sep 2025
Q2 2025 35% +42% 30 Jun 2025
Q1 2025 42% +52% 31 Mar 2025
Q4 2024 297% +317% 31 Dec 2024
Q3 2024 -5% -2% -50% 30 Sep 2024
Q2 2024 -7% -5% -181% 30 Jun 2024
Q1 2024 -10% -8% -397% 31 Mar 2024
Q4 2023 -19% -18% -1199% 31 Dec 2023
Q3 2023 -3% -1% -59% 30 Sep 2023
Q2 2023 -3% 30 Jun 2023
Q1 2023 -2% 31 Mar 2023
Q4 2022 -1% 31 Dec 2022
Q3 2022 -2% 30 Sep 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.